These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 16344570

  • 1. Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
    Ghosh S, Chaudhary R, Carpani M, Playford RJ.
    Gut; 2006 Jan; 55(1):6-8. PubMed ID: 16344570
    [Abstract] [Full Text] [Related]

  • 2. [Role of thiopurine agents in ulcerative colitis].
    Chaparro M, Gisbert JP.
    Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
    [Abstract] [Full Text] [Related]

  • 3. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [Abstract] [Full Text] [Related]

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC, Butler WJ.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
    [No Abstract] [Full Text] [Related]

  • 6. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
    Axelrad JE, Roy A, Lawlor G, Korelitz B, Lichtiger S.
    World J Gastroenterol; 2016 Dec 14; 22(46):10103-10117. PubMed ID: 28028358
    [Abstract] [Full Text] [Related]

  • 7. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ.
    Semin Drug Treat; 1974 Dec 14; 3(4):339-49. PubMed ID: 4150770
    [No Abstract] [Full Text] [Related]

  • 8. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.
    Haveran LA, Sehgal R, Poritz LS, McKenna KJ, Stewart DB, Koltun WA.
    Dis Colon Rectum; 2011 Jan 14; 54(1):15-20. PubMed ID: 21160308
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI.
    Gastroenterologist; 1995 Jun 14; 3(2):141-52. PubMed ID: 7640945
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Immunosuppressive therapy of ulcerative colitis and Crohn's disease].
    Reitzig P, Apostoloff E, Lisewski G, Spranger GD.
    Dtsch Gesundheitsw; 1973 Jun 14; 28(5):238-40. PubMed ID: 4722981
    [No Abstract] [Full Text] [Related]

  • 18. Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.
    Persley K, Scherl E, Rubin P.
    Am J Gastroenterol; 2001 Dec 14; 96(12):3444-5. PubMed ID: 11774971
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T, Iwao Y, Yajima T, Inoue N, Ueno Y, Takaishi H, Watanabe M, Ishii H.
    J Gastroenterol; 1995 Nov 14; 30 Suppl 8():121-3. PubMed ID: 8563872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.